Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03518294
What this trial is testing

NASH Fitness Intervention in Thrombosis Trial (NASHFit)

Who this might be right for
Liver DiseasesBlood DisorderDigestive System Disease
Milton S. Hershey Medical Center 28
Not applicableStudy completedNCT03276039
What this trial is testing

Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus

Who this might be right for
Non Alcoholic Fatty Liver Disease
Ain Shams University 70
Not applicableStudy completedNCT04561895
What this trial is testing

Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients

Who this might be right for
NAFLDNASH - Nonalcoholic Steatohepatitis
Cairo University 224
Early research (Phase 1)UnknownNCT02469272
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Lifespan 5
Post-approval studies (Phase 4)Study completedNCT02285205
What this trial is testing

A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
Yonsei University 38
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Not applicableStudy completedNCT02217605
What this trial is testing

31P Magnetic Resonance Spectroscopy Fructose Study

Who this might be right for
Healthy
Stephen Bawden 10
Testing effectiveness (Phase 2)Ended earlyNCT03551522
What this trial is testing

Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Gilead Sciences 181
Not applicableStudy completedNCT04049396
What this trial is testing

Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Lida Nejati 50
Not applicableUnknownNCT02579408
What this trial is testing

Quantifying Steatosis in Liver Transplant Donors

Who this might be right for
Non-alcoholic Fatty Liver DiseaseEvidence of Liver Transplantation
The University of Hong Kong 100
Testing effectiveness (Phase 2)UnknownNCT04772352
What this trial is testing

Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout

Who this might be right for
Nonalcoholic Fatty Liver Disease
Ningbo No. 1 Hospital 200
Early research (Phase 1)Ended earlyNCT04766476
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Bristol-Myers Squibb 9
Not applicableLooking for participantsNCT04525833
What this trial is testing

Liver Disease and Other Systemic Diseases

Who this might be right for
Liver DiseasesHumansProgression+7 more
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 15,000
Not applicableUnknownNCT05987748
What this trial is testing

The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Leiden University Medical Center 40
Early research (Phase 1)Study completedNCT04137055
What this trial is testing

Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 Pharmacokinetics

Who this might be right for
Nonalcoholic Steatohepatitis
Guangdong Raynovent Biotech Co., Ltd 104
Not applicableStudy completedNCT05499585
What this trial is testing

Treating Pediatric NAFLD with Nutrition

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver DiseasesLiver Fat+2 more
University of California, San Diego 20
Not applicableUnknownNCT03848390
What this trial is testing

Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).

Who this might be right for
Non-Alcoholic Fatty Liver Disease
The University of Texas Health Science Center, Houston 40
Testing effectiveness (Phase 2)Study completedNCT04480710
What this trial is testing

CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

Who this might be right for
NASH - Nonalcoholic SteatohepatitisFibrosis, LiverNAFLD - Nonalcoholic Fatty Liver Disease
Hepion Pharmaceuticals, Inc. 47
Not applicableUnknownNCT02702479
What this trial is testing

Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk

Who this might be right for
ObesityDyslipidemiaPrediabetes+5 more
University of Toronto 1
Not applicableUnknownNCT06166797
What this trial is testing

Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Massachusetts General Hospital 60
Next Page